Schenkein was previously chief executive officer of Agios Pharmaceuticals, which he grew from a small closely held startup to a $3.1 billion biotechnology company
from RSS Feeds : RSS Feed - NDTV Gadgets360.com http://bit.ly/2BsSxDa
Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat.
0 Comments